Science 37 Holdings, Inc.

Science 37 Holdings, Inc. (Nasdaq: SNCE) is a decentralized clinical trial technology company that entered the public markets through its merger with LifeSci Acquisition Corp, a blank-check vehicle sponsored by LifeSci Capital, which completed its SPAC IPO in 2020. The business combination closed in October 2021, listing Science 37 on Nasdaq and positioning the company within the healthcare technology and clinical research services sector. Science 37 provides software and operational infrastructure enabling remote, decentralized clinical trials for pharmaceutical and biotechnology sponsors. The May 2023 Form 8-K reflects the company's continued public reporting obligations post-merger. For complete filing history, sponsor details, and post-merger performance data on SNCE, sign up for full access at SpacDesk.